Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Patent
1997-09-30
1999-01-12
Shah, Mukund J.
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
C07D26702, C07D28102
Patent
active
058592393
ABSTRACT:
Compounds of the formula ##STR1## wherein X.sub.1 is ##STR2## are disclosed. These compounds possess inhibitory activity against angiotensin converting enzyme and neutral endopeptidase and thus useful as cardiovascular agents.
REFERENCES:
patent: 4105776 (1978-08-01), Ondetti et al.
patent: 4192945 (1980-03-01), Ondetti
patent: 4339600 (1982-07-01), Ondetti et al.
patent: 4374829 (1983-02-01), Harris et al.
patent: 4409146 (1983-10-01), Thorsett
patent: 4410520 (1983-10-01), Watthey
patent: 4415496 (1983-11-01), Harris et al.
patent: 4460579 (1984-07-01), Karanewsky
patent: 4465679 (1984-08-01), Huang et al.
patent: 4470988 (1984-09-01), Watthey
patent: 4473575 (1984-09-01), Watthey
patent: 4477464 (1984-10-01), Slade et al.
patent: 4512924 (1985-04-01), Attwood et al.
patent: 4537885 (1985-08-01), Watthey
patent: 4539150 (1985-09-01), Katakami et al.
patent: 4575503 (1986-03-01), Watthey
patent: 4584294 (1986-04-01), Ruyle
patent: 4584932 (1986-04-01), Sugihara et al.
patent: 4587050 (1986-05-01), Harris et al.
patent: 4587238 (1986-05-01), Harris et al.
patent: 4594341 (1986-06-01), Cheung et al.
patent: 4617301 (1986-10-01), Patchett et al.
patent: 4629787 (1986-12-01), Harris et al.
patent: 4680392 (1987-07-01), Harris et al.
patent: 4699905 (1987-10-01), Yangisawa et al.
patent: 4711884 (1987-12-01), Karanewsky
patent: 4734410 (1988-03-01), Yanagisawa et al.
patent: 4749688 (1988-06-01), Haslanger
patent: 4824832 (1989-04-01), Flynn et al.
patent: 4873235 (1989-10-01), Parsons et al.
patent: 4963539 (1990-10-01), Delaney
patent: 4973585 (1990-11-01), Flynn et al.
patent: 5075302 (1991-12-01), Neustadt
patent: 5098934 (1992-03-01), Vevert et al.
patent: 5190974 (1993-03-01), Clemence et al.
patent: 5208236 (1993-05-01), Neustadt
patent: 5225401 (1993-07-01), Seymour
patent: 5232920 (1993-08-01), Neustadt
patent: 5233516 (1993-08-01), Delaney
patent: 5238924 (1993-08-01), Smith
patent: 5262436 (1993-11-01), Haslanger et al.
patent: 5362727 (1994-11-01), Robl
patent: 5366973 (1994-11-01), Flynn et al.
patent: 5532359 (1996-07-01), Marsters et al.
Watthey et al. J. Med. Chem., 28, pp. 1511-1516 (1985).
Slade et al., J. Med. Chem., 28, pp. 1517-1521 (1985).
Thorsett et al., J. Med. Chem. 29 pp. 251-260 (1986).
Yanagisawa et al., J. Med. Chem., 30, pp. 1984-1991 (1987).
Yanagisawa et al., J. Med. Chem. 31 pp. 422-428 (1988).
Parsons et al., Biochem and Biophysical Research Comm. 117, pp. 108-113 (1993).
Atwood et al., FEBS Letters, vol. 165, pp. 201-206 (1984).
Natoff et al., Drugs Of the Future, vol. 12, pp. 475-483 (1987).
Itoh et al., Chem. Pharm. Bull., vol. 34, pp. 1128-1147 and 2078-2089 (1986).
Flynn, Tetrahedron Letters, vol. 31, pp. 815-818 (1990).
Thorsett, Actual Chim. Ther., vol. 13, pp. 257-268 (1986).
Atwood et al., J. Chem. Soc. Perkin Trans I (1986) pp. 1011-1029.
Robl, Tetrahedron Letters, vol. 35, pp. 393-396 and 1393-1396, (1994).
Delaney et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 1783-1788 (1994).
Robl et al., Bioorganic & Medicinal Chemistry Letters, vol. 4, pp. 1789-1794 (1994).
Robl et al., Bioorganic & Medicinal Chemistry Letters, vol. 4. pp. 2055-2060 (1994).
Das et al., Bioorganic & Medicinal Chemistry Letters, vol. 4. pp. 2193-2198 (1994).
Bolos et al., Tetrahedron , vol. 48, pp. 9567-9576 (1992).
Bolos et al., J. Org. Chem., 57 3535-3539 (1992).
Adams et al. Synthetic Communications, vol. 18, 2225-2231 (1988).
Chackalamannil et al., Bioorganic & Medicinal Chemistry Letters, vol. 2, pp. 1003-1006 (1992).
Flynn et al., J. Med. Chem., 36 pp. 2420-2423 (1993).
Robl et al., J. Am. Chem. Soc., 116 pp. 2348-2355 (1994).
Robl. et al. Bioorg. Med. Chem. Lett., 4, 1795-1800 (1994).
Boyer, "Cirrhosis of the Liver and its Major Sequelae" in Wyngaardon et al., Gril Textbook of Medicine, vol. 1 (Philadelphia, Saunders Co., 1992) pp. 786-789.
Dussaule et al., Jour. of Clinical Endocrinology and Metabolism, vol. 72, pp. 653-659, 1991.
Loffi et al., Gastroenterology, vol. 96, pp. 167-177, 1989.
Fyhrquist et al., The Lancet, Dec. 21/28, 1985, pp. 1439-1440.
Karanewsky Donald S.
Robl Jeffrey A.
Davis Stephen B.
E. R. Squibb & Sons Inc.
Kifle Bruck
Shah Mukund J.
LandOfFree
Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mercaptoalkanoylamino and acylmercaptoalkanoylamino benzoxazepin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1517883